Molecular therapy for Osteoporosis: Stress induced Inflammatory cytokine Resistin increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 14/September/2014, 05.54 am

Molecular therapy for Osteoporosis: Stress induced Inflammatory cytokine Resistin increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 14/September/2014, 05.54 am

Molecular therapy for Osteoporosis: Stress induced Inflammatory cytokine Resistin increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 14/September/2014, 05.54 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, Molecular therapy for Osteoporosis:  Stress induced Inflammatory cytokine  Resistin  increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 14/September/2014, 05.57 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that Inflammatory cytokine  Resistin  may inhibit bone formation.  Thus, pharmacological formulations encompassing “ Resistin  inhibitor” may be used to treat Osteoporosis.

Share
Start Typing